LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Free cash flow 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$13.6MFY2025 · since FY2016: -$18.9M → -$13.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.6M | +24.9% |
| FY2024 | -$18.1M | — |
| FY2022 | -$48.8M | -1647.9% |
| FY2021 | -$2.8M | +90.5% |
| FY2020 | -$29.3M | -1.9% |
| FY2019 | -$28.7M | -107.9% |
| FY2018 | -$13.8M | -302.1% |
| FY2017 | $6.8M | +136.1% |
| FY2016 | -$18.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LFCR financial trends
LFCR RevenueLFCR Net incomeLFCR Net marginLFCR Gross profitLFCR Gross marginLFCR Operating incomeLFCR Operating marginLFCR Operating cash flowLFCR Capital expendituresLFCR Return on equityLFCR Stock buybacksLFCR Dividends paidLFCR Total assetsLFCR Total liabilitiesLFCR Shareholders’ equityLFCR overview →